Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 4, 2026, 2:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–40 of 40 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Oral Vancomycin placebo Clear all

Conditions: Bacterial Infections
Interventions: Debio 1450 IV, Debio 1450 Oral, Linezolid, Debio 1450 Oral Placebo, Linezolid Placebo, Vancomycin IV; Drug
Lead sponsor: Debiopharm International SA; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 22
States / cities: Anaheim, California • Buena Park, California • Chula Vista, California + 17 more

Conditions: Pre-Diabetes
Interventions: Vancomycin, Placebo, Neomycin, Clindamycin, Fecal Microbiota Transplantation; Drug · Other · Procedure
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 70 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Clostridium Difficile Infection
Interventions: Vancomycin, Placebo; Drug · Other
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years and older
Enrollment: 1,294 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 3
States / cities: Dearborn, Michigan • Royal Oak, Michigan • Troy, Michigan

Conditions: Pitt Hopkins Syndrome
Interventions: vancomycin, magnesium citrate, microbiota, placebo vancomycin, real magnesium citrate, placebo microbiota; Combination Product
Lead sponsor: Arizona State University; Other
Eligibility: 7 Years to 17 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Ulcerative Colitis, FMT, Fecal Microbiota Transplant
Interventions: Metronidazole, Placebo, Vancomycin, Fecal Microbiota Transplantation; Drug · Biological
Lead sponsor: Ari M Grinspan; Other
Eligibility: 18 Years to 75 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Clostridium Difficile, Spinal Cord Injury
Interventions: Fidaxomicin 200 mg, Placebo, Vancomycin; Drug
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Antibiotic Resistant Strain
Interventions: Encapsulated fecal microbiota preparation, Encapsulated placebo; Biological
Lead sponsor: Microbiome Health Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Indianapolis, Indiana • Madison, Wisconsin

Conditions: Allergy, Peanut, Peanut Allergy, Peanut Hypersensitivity, Peanut-Induced Anaphylaxis, Food Allergy, Food Allergy Peanut
Interventions: Microbial Transplantation Therapy, Antibiotic, Placebo (in place of MTT), Placebo (in place of antibiotics), Oral Immunotherapy (OIT); Biological · Drug · Other
Lead sponsor: Rima Rachid; Other
Eligibility: 12 Years to 17 Years
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Clostridium Difficile Infection
Interventions: Bezlotoxumab, Placebo, Antibacterial drug treatment (ABD); Biological · Drug
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 1 Year to 17 Years
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 21
States / cities: Los Angeles, California • San Francisco, California • Aurora, Colorado + 18 more

Conditions: Clostridium Difficile Infection, Diarrhea
Interventions: Oral Vancomycin, Placebo, Toxin enzyme immunoassay, Nuceleic acid amplification test; Drug · Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Crohn's Disease
Interventions: Fluconazole, Vancomycin, Neomycin, Ciprofloxacin, Polyethylene Glycol 3350, Promethazine, Fluconazole placebo; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 75 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cirrhosis, Hepatic Encephalopathy
Interventions: Placebo, VE303, oral vancomycin; Drug
Lead sponsor: Patricia Bloom; Other
Eligibility: 18 Years to 75 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Clostridium Difficile Infection
Interventions: Vancomycin, fruit juice/placebo; Drug · Dietary Supplement
Lead sponsor: Corewell Health West; Other
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Grand Rapids, Michigan

Conditions: Clostridium Difficile Infection
Interventions: Oral Vancomycin, Placebo; Drug
Lead sponsor: Rochester General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Infection Due to Resistant Organism
Interventions: Fecal Microbiota Transplant (FMT), Bowel preparation, Stool or perirectal swab sampling, Fasting; Biological · Procedure · Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: End Stage Renal Disease
Interventions: Vancomycin, Placebo; Drug · Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 80 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Study of Debio 1450 for Bacterial Skin Infections

Interventional Bioremediation of Microbiota in Metabolic Syndrome

Screening to Prophylax Against Clostridium Difficile Infection -

MTT for Children With Both Pitt Hopkins Syndrome and Gastrointestinal Disorders

Refined Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC)

Use Of Oral Fidaxomicin Vs. Oral Vancomycin For Clostridium Difficile Infection In Patients With Spinal Cord Injury

A Trial of Encapsulated Fecal Microbiota for Vancomycin Resistant Enterococcus Decolonization

Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients

Bezlotoxumab (MK-6072) Versus Placebo in Children With Clostridium Difficile Infection (CDI) (MK-6072-001)

TOX NEG Trial: Clostridium Difficile Diagnosis and Treatment

Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease

VE303 for Treatment of Hepatic Encephalopathy (HE)

Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection

Oral Vancomycin for Preventing Clostridium Difficile Recurrence

FMT for MDRO Colonization After Infection in Renal Transplant Recipients

The Effect of an Antibiotic on the Production of Uremic Toxins by the Gut Microbiome